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ABSTRACT
Background: Foot-and-mouth vaccines are an important tool in the control and eradication of the disease. In order to be 
commercialized, vaccines produced in Brazil undergo an evaluation process by health authorities, which includes sterility 
testing, residual active virus, potency, thermal stability, volume and non-structural protein activity. Sterility tests described 
in the Brazilian Pharmacopeia and by the World Organization for Animal Health (OIE) include direct inoculation and 
membrane filtration methods. The objective of the present study was to evaluate these two methods used to analyze sterility 
of vaccines against foot-and-mouth disease produced in Brazil. 
Materials, Methods & Results: Vaccines produced by the six main laboratories in Brazil were initially tested for filtration 
capacity. The sensitivity of the two techniques was determined artificially contaminating vaccines using known bacterial 
concentrations. Vaccines (9 bottles) from the same manufacturer were inoculated with 5 mL of steady-state growths of 
Pseudomonas aeruginosa, Candida albicans, and Clostridium sporogenes to final concentrations of 0.1, 1 and 10 CFU/
mL and a final volume of 55 mL. Bottles were manually shaken for 1 min to complete homogenization of contents. Then, 
10 mL of each flask were used in assessment of the direct inoculation method, and 10 mL were used to evaluate the 
membrane filtration technique. Direct inoculation was carried out inoculating 1 mL of the experimentally contaminated 
vaccine in five tryptic soy broth (TSB) and fluid thioglycollate medium (FTM) bottles. The membrane filtration technique 
was carried out filtrating 10 mL of the challenged vaccines in a peristaltic pump system (SteritestTM Pump System), where 
vaccines were initially solubilized in Triton X-100 to promote filtration. Next, membranes are incubated in TSB and FTM. 
These use two types of culture medium, tryptic soy broth (TSB) and fluid thioglycollate medium (FTM), with incubation 
times of 20-25ºC and 30-35ºC, respectively, to detect fungi, yeasts, and aerobic and anaerobic bacteria. The medium is 
incubated for 14 days, to enable the detection of slow-growth microorganisms that may be in a latent stage or weakened 
due to the extreme conditions of the production process (like the use of cleaning and disinfection agents, ultraviolet light, 
and preservers, for instance). All vaccines were effectively filtered in the SteritestTM Pump System. Membrane filtration 
and direct inoculation presented the same sensitivity to detect yeasts (0.1 CFU/mL) and anaerobic organisms (1 CFU/mL). 
For the detection of aerobic organisms, membrane filtration was 100 times more sensitive, compared to direct inoculation.
Discussion: The specialized literature also reports that, apart from the higher sensitivity, membrane filtration affords to 
reduce contamination during the procedures, since it is carried out in a closed system. In addition, it is indicated in the 
analysis of large sample volumes. Moreover, membrane filtration reduces the occurrence of false positive results, since 
it removes the excess vaccine volume from the culture medium, which may be mistaken for turbidity caused by bacterial 
growth. In this sense, the membrane filtration technique is more appropriate in the control of vaccine sterility in foot-and-
mouth disease prevention strategies, and is an interesting tool to improve quality control of the product. 
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INTRODUCTION
Foot-and-mouth disease is one of the most 
important conditions that affect split-hoofed animals. 
It infects cattle, buffalo, pigs, sheep, and goats, as well 
as approximately 70 wild species [7]. This vesicular 
disease is caused by a virus of the genus Aphtovirus, 
family Picornaviridae, with high infection rates in 
livestock worldwide [8]. Vaccines against foot-and-
mouth disease are an important tool in the control 
of the condition in endemic regions [14]. Currently, 
the vaccine is produced as a primary two-phase oil-
in-water emulsion. The aqueous phase contains virus 
inactivated with a first-order inactivator, while the oil 
phase is prepared with mineral oil as adjuvant [1]. In 
Brazil, vaccines can only be commercialized after 
official evaluation procedures by the Ministry of Ag-
riculture, Livestock and Food Supply. These include 
sterility, volume, residual active virus, potency, thermal 
stability and non-structural protein activity [2]. Sterility 
testing described in the Brazilian Pharmacopeia [3] and 
the World Organization for Animal Health [9] include 
direct inoculation and membrane filtration methods. 
These use two types of culture medium, tryptic soy 
broth (TSB) and fluid thioglycollate medium (FTM), 
with incubation temperature of 20-25ºC and 30-35ºC, 
respectively, to detect fungi, yeasts, besides aerobic 
and anaerobic bacteria [3,9]. 
The aim of the present study was to evaluate 
the efficiency of two microbiological methods (direct 
inoculation and membrane filtering) described in the 
literature in the quality control of sterility of vaccines 
against foot-and-mouth disease produced in Brazil.
MATERIALS AND METHODS
Vaccines
All samples used had been tested using the 
inoculation method by manufacturers as part of their 
quality control routine, with negative results. However, 
filterability was of foot-and-mouth disease vaccines 
(commercialized in 50 mL bottles) from six different 
manufacturers was assessed. The vaccines tested were 
from the main Brazilian producers and exporters of 
the medicament. 
Strains and preparation of microorganism dilutions
Yeasts as well as Gram-positive, Gram-negative, 
aerobic, anaerobic and spore-former microorganisms 
were used. All were from the American Type Culture 
Collection (ATCC) (Table 1). Serial decimal dilutions of 
steady-state cultures were prepared using peptone saline 
0.1% to obtain 10, 1 and 0.1 colony forming units (CFU)/
mL. These solutions were used to evaluate effectiveness 
of growth media and to experimentally challenge vac-
cines so as to assess sensitivity of the methods direct 
inoculation and membrane filtering. Colony forming 
units were counted in tryptose sulfite cycloserine agar 
(TSC)1 for Clostridium sporogenes and plate count agar 
(PCA)2 for the other microorganisms.
Growth media and reactants
The TSB, FTM, and fluid D media, as well as the 
cassettes used in the membrane filtration technique were 
purchased from Millipore, USA. Triton solutions (Triton 
X-100®)3 0.1% and 10% were prepared to test the mem-
brane filtration technique. Microorganisms were counted 
using the media peptone water and TSC and PCA.
Effectiveness of growth media
To assess whether growth media were able 
to promote microbial development, 1 mL of the 0.1, 
1, and 10 CFU/mL solutions of the microorganisms 
P. aeruginosa and C. albicans was inoculated in TSB 
and FTM, while C. sporogenes was inoculated in FTM 
for 14 days, at temperatures given in Table 1. The same 
solutions were plated on PCA and TSC (anaerobiosis) 
and incubated at 30-35ºC for 48 h. Then, colonies were 
counted and concentrations were evaluated. 
Negative controls were used in all analyses. 
Growth media were incubated as described, but with-
out inocula.
Experimental challenge of vaccines
Vaccines (9 bottles) from the same manufac-
turer were inoculated with 5 mL of steady-state growths 
of P. aeruginosa, C. albicans, and C. sporogenes to 
final concentrations of 0.1, 1 and 10 CFU/mL and a 
final volume of 55 mL. Bottles were manually shaken 
for 1 min to complete homogenization of contents. 
Then, 10 mL of each flask were used in assessment of 
the direct inoculation method, and 10 mL were used 
to evaluate the membrane filtration technique.
Direct inoculation method
To determine sensitivity, bottles containing 
20 mL of TSB2 and of FTM2 were inoculated (in five 
replicates) with 1 mL of the vaccines experimen-
tally challenged with P. aeruginosa, C. albicans, and 
C. sporogenes. Tubes were incubated at the tempera-
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tures given in Table 1, for 14 days, and readings were 
made every 2 days. Microbial growth was observed as 
turbidity of the TSB medium and the turbidity or fading 
of the pink halo in the FTM medium.
Membrane filtration method
Filterability of vaccines was evaluated using 
the Steritest™ method. Vaccines (50 mL) of six differ-
ent manufacturers were submitted to the same filtration 
protocol. All analyses were carried out in the compact 
Steritest™ pump system4. Triton3 10% (50 mL) was 
used to moist the membrane in each canister. Then, 
10 mL of the vaccine were homogenized with 50 mL 
of Triton 10%. After filtration, canisters were washed 
with 100 mL of Triton 10% twice and 100 mL Triton 
0.1% once. Finally, canisters were washed with 100 mL 
fluid D, to remove excess Triton, and incubated with 
100 mL of FTM and TSB for 14 days, respectively, at 
30-35ºC and 20-25ºC.
Sensitivity was analyzed submitting the vac-
cines experimentally challenged with P. aeruginosa, 
C. albicans, and C. sporogenes to the protocol de-
scribed above. 
Readings were carried out every two days. 
Microbial growth was observed as turbidity of the TSB 
medium and the turbidity or fading of the pink halo in 
the FTM medium.
Confirmation of contamination
Confirmation of turbidity of the culture media 
used in the comparison between direct inoculation and 
membrane filtration and caused by growth of microor-
ganisms inoculated in the vaccine was confirmed seed-
ing the FTM medium in TSC agar (under anaerobic 
conditions) and incubation for 48 h at 30-35ºC. In turn, 
the TSB medium was seeded on PCA agar and potato 
agar plates, with incubation at 30-35ºC (48 h) and at 
20-25ºC (72 h), respectively.
Table 1. List of microorganisms used in the evaluation of direct inoculation and membrane filtration.
Strain ID Anaerobic/aerobic Gram stain Incubation temperature (°C)
Pseudomonas aeruginosa ATCC27853 aerobic Gram-negative rods 30-35
Clostridium sporogenes ATCC11437 anaerobic Gram-positive rods 30-35
Candida albicans ATCC10231 aerobic Yeast 20-25
RESULTS
The TSB and FTM media promoted the growth 
of P. aeruginosa, C. albicans, and C. sporogenes, with 
the three solutions used (0.1, 1, and 10 CFU/mL).
Independently of manufacturer, all vaccines 
were filterable in the Steritest™ system, and no nega-
tive control presented bacterial growth.
To determine the sensitivity of direct inocula-
tion and of membrane filtration, the two techniques 
were conducted in parallel, using the same vaccine 
samples experimentally challenged with bacterial 
contamination. Table 2 shows how the two methods 
compare, in terms of sensitivity. The different microbial 
dilutions were tested (quintuplicates) in direct inocula-
tion. Replicates of the same dilution presented the same 
result (either positive, or negative).
In order to confirm that turbidity of media was 
caused by microorganisms inoculated in vaccines, 
cultures were seeded on solid medium. Bacterial 
growth in dishes containing agar TSC were typical 
of Clostridium sp. (black colonies), while the potato 
agar dishes exhibited common yeast cultures (smooth, 
Table 2. Results (CFU/mL) of sensitivity assays for direct inoculation and membrane filtration.
C. albicans P. aeruginosa C. sporogenes
10 1 0.1 10 1 0.1 10 1 0.1
Direct inoculation
FTM 5/5 5/5 5/5 5/5 0/5 0/5 5/5 5/5 0/5
TSB 5/5 5/5 5/5 5/5 0/5 0/5 NA NA NA
Membrane filtration
FTM 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 0/1
TSB 1/1 1/1 1/1 1/1 1/1 1/1 NA NA NA
NA: not applicable.
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shiny, white-to-yellowish cultures). PCA that exhibited 
bacterial growth were used in Gram staining and bio-
chemical assays. Candida albicans colonies on PCA 
had typical morphology and color in the Gram stain-
ing (pleomorphic and Gram-positive staining), while 
colonies of Pseudomonas aeruginosa were rod-shaped, 
Gram-negative, and positive in the oxidase assay.
DISCUSSION
Like any other biologically sourced product, 
vaccines against foot-and-mouth disease are produced 
aseptically and tested for sterility during the various 
production stages, since they cannot be submitted to 
one single final sterilization process. Therefore, sterility 
evaluations, together with asepsis in processes, environ-
mental surveillance, and the use of sterilized equipment 
and reactants ensure that the end product meets sterility 
requirements [10]. Sterility implies the absence of any 
viable microorganism able to pose hazards during or 
after administration or use of a product [12]. A 10-6 ste-
rility level is usually acceptable in processes adopted by 
the pharmaceutical industry. In other words, this means 
less than one viable microorganism in one million units 
produced [5]. We evaluated solutions of 10, 1, and 0.1 
CFU/mL, as recommended in literature [10]. Sensitivity 
of the membrane filtration technique was identical to 
that of direct inoculation in the detection of yeasts (0.1 
CFU/mL) and of anaerobic microorganisms (1 CFU/
mL). As for the detection of aerobic microorganisms, 
membrane filtration was 100 times more sensitive than 
direct inoculation. Similarly, the first technique is more 
sensitive when compared with plating on solid medium 
[6] and with direct inoculation [3,4]. In fact, membrane 
filtration detects as many as 9% more positive samples 
(at 1 CFU/mL), compared to direct inoculation [10].
The inactivator used in the production of the vac-
cine against the foot-and-mouth disease virus also acts 
against other microorganisms, reducing the microbial 
load of experimentally challenged vaccines [3]. More-
over, the number of viable microorganisms drops with 
time, due to the kinetic of bacterial growth [13]. With a 
view to simulating contamination during the production 
process, we chose to inoculate vaccines with known 
concentrations of microorganisms. Besides, vaccines 
were analyzed immediately after experimental challenge 
with these pathogens, in order to minimize the loss of 
viability of these microorganisms. For this reason, the 
higher sensitivity of the membrane filtration technique is 
explained by the fact that the microorganism is kept from 
the product during incubation (which does not occur in 
direct inoculation). Ultimately, this segregation allows 
weakened pathogens to recover more efficiently [10]. 
Membrane filtration has some advantages over 
direct inoculation: (i) it reduces contamination during 
analysis, since it is carried out in a closed peristaltic 
pump [3]; (ii) it enables the analysis of larger samples 
[11]; (iii) it reduces the chances of false positives, since 
excess vaccine is removed from the medium, which oth-
erwise would increase turbidity, influencing results [3]. 
CONCLUSION
In conclusion, the sensitivity of the membrane 
filtration technique is similar to that of direct inocula-
tion in the detection of fungi, yeasts, and anaerobic 
bacteria in vaccines against foot-and-mouth disease, 
though it is more sensitive to detect aerobic microor-
ganisms. In this sense, the membrane filtration tech-
nique is the most appropriate in the determination of 
sterility in vaccines against foot-and-mouth disease. 
MANUFACTURERS   
1Oxoid. Basingstoke. Hampshire, UK.
2Himedia. Curitiba, PR, Brazil.
3Sigma-Aldrich. Sant Louis, MO, EUA.
4Merck Millipore. Darmstadt, Alemanha.
Declaration of interest. The authors report no conflicts of 
interest. The authors alone are responsible for the content and 
writing of the paper.
REFERENCES
1 Abaracón B. & Olascoaga R.C. 1984. Vacinas contra a febre aftosa. A Hora Veterinária. 17: 45-52.
2 Ministério da Agricultura Pecuária e Abastecimento. 2008. Instrução Normativa 50/2008 de 24/09/2008. Regulamento 
Técnico para a Produção, Controle da Qualidade, Comercialização e Emprego de Vacinas Contra a Febre Aftosa, 7p. Disponível 
em: <https://www.diariodasleis.com.br/busca/exibelink.php?numlink=1-77-23-2008-09-23-50>. [Acessed online June 2015.]
3 Agência Nacional de Vigilância Sanitária. 2010. Farmacopéia Brasileira. 5.ed. v.1. Métodos biológicos, Ensaios 
biológicos e Microbiológicos. pp.256-260. Disponível em: <http://www.anvisa.gov.br/hotsite/cd_farmacopeia/pdf/
volume1.pdf>. [Acessed online May 2015].
5                                                                                                           C.R. Rodenbusch, L.R. Silveira, A.R. Bavaresco & M.V.B. Sfoggia. 2016. An Assessment of Microbiological Methods to Test Sterility 
of Foot-and-mouth Disease Vaccines Produced in Brazil.                                                                                                                  Acta Scientiae Veterinariae. 44: 1343.
www.ufrgs.br/actavet
1343
4 Cortés A., Sandino C. & Arias J. 2003. Validación de la prueba de esterilidad para vacunas virales preparadas em 
vehiculos oleoso y acuoso. Revista de la Faculdad de Farmacia. 45: 36-43.
5 European Commission. 2012. Guide to Good Manufacturing Practice for Medical Products for Human and Veteri-
nary Use. Manufacture of Sterile Medicinal Products. 16p. Disponível em: <http://ec.europa.eu/health/files/eudralex/
vol-4/2008_11_25_gmp-an1_en.pdf >. [Acessed online May 2015].
6 Hernandez-Lopez J., Guzman-Murillo A. & Vargas-Albores F. 1995. Quantification of pathogenic marine vibrio 
using membrane filter technique. Journal of Microbiology Methods. 21: 143-149.
7 Jamal S.M. & Belsham G.J. 2013. Foot-and-mouth disease: past, present and future. Veterinary Research. 44: 116-
129. 
8 MacLachlan N.J. & Dubovi E.J. 2011. Picornaviridae. In: Fenner’s Veterinary Virology. London: Academic Press, 
pp.431-435.
9 OIE - World Organization for Animal Health. 2013. Manual of diagnostic test and vaccines for terrestrial animals. 
Tests for Sterility and Freedom from Contamination of Biological Materials, 10p. Disponível em: <http://www.oie.int/
fileadmin/Home/eng/Health_standards/tahm/1.01.07_TESTS_FOR_STERILITY.pdf>. [Acessed online June 2015].
10 Parveen S., Kaur S., David S.A.W., Kenney J.L., McCormick W.M. & Gupta R.K. 2011. Evaluation of growth 
based rapid microbiological methods for sterility testing of vaccines and other biological products. Vaccine. 9: 8012-
8023.
11 Pinto T.J.A., Kaneko T.M. & Ohara M.T. 2003. Controle biológico de qualidade de produtos farmacêuticos, cor-
relatos e cosmético. 2.ed. São Paulo: Atheneu, 325p.
12 Sharp J. 1995. What do we mean by sterility? PDA Journal of Pharmaceutical Science and Technology. 49: 90-92.
13 Von Woedtke T. & Kramer A. 2008. The limits of sterility assurance. GMS Krankenhaushygiene. Interdisziplinär. 3: 
1-10.
14 Willems T., Lefebvre D.J., Goris N., Diev V.I., Kremenchugskaya G.P., Haas B. & De Clercq K. 2012. Character-
istics of serology-based vaccine potency models for foot-and-mouth disease virus. Vaccine. 30: 5849-5855.
